From all appearances, the company discussed in today’s article is a digital health firm. Analysts at Citi Research, however, view the company as “a biotech in digital health clothing” – one that, thanks to the vast amount of information it has collected through its genetic testing business, has the potential to become a powerful drug developer. For more, CLICK HERE.
This “Biotech In Digital Health Clothing” Has The Potential To Become A Powerful Drug Maker
- by Alex Clarke
Tags:Biotech SectorBiotech StocksDigital Health ClothingDigital Health FirmDrug DeveloperGenetic TestingInvestingStock Market